Pharm2Farm’s antiviral mask: How does it work?

Instead of the usual three-ply design, the five-ply surgical mask includes an additional antiviral inner layer which incorporates nano-copper created using a patented process developed at the university.

The copper, which is embedded into the mask material, has ions that are emitted once in contact with a virus and this then creates an interaction with the virus’s genetic material causing it to die and stop reproducing.

Because they are spherical, nanoparticles have a large surface area making the approach more effective at killing the virus. The antiviral inner layer ensures additional protection for both the wearer and those in proximity.

Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

More articles like this

Face masks are back for many Americans

Face mask requirements are returning to the United States in some communities and workplaces, along with directives for mandatory coronavirus vaccinations, in a new push to curb the easily transmissible delta variant of the infection that has already

Face masks sales soar after fears rise amidst Freedom Day

Freedom day has arrived… But despite the lifting of Covid restrictions, many experts are warning that Coronavirus infections will continue to rise. Professor Neil Ferguson, from Imperial College London and a member of the Scientific Advisory Group for Emergencies (SAGE) said

Mask which kills 99.9% of COVID-19 within 5 minutes of contact

An innovative anti-viral mask, Pro-Larva, has been developed by Pharm2Farm, which kills 99.9% of COVID-19 within 5 minutes of contact. The mask not only protects the wearer but also those around the wearer, using copper nanoparticle technology. Where

RMS signs agreement with PIC Consultants

Remote Monitored Systems has announced that it has signed an agreement with PIC Consultants Ltd. to supply high quality retail hydroponic nutrients for distribution in the UK market. The London-listed tech company said that under the deal, PIC

Remote Monitored Systems signs hydroponics agreement

Remote Monitored Systems PLC announced on Monday that it has signed an agreement with PIC Consultants Ltd. to supply high quality retail hydroponic nutrients for distribution in the UK market. The London-listed tech company said that under the

Remote Monitored Systems growing revenues of £104k

Remote Monitored Systems plc (LON:RMS) has announced its final results for the year end 31 December 2020. Company Highlights Financials • Growing revenues of £104k (2019: £52k) • Losses increased to £1.53m (2019: £0.59m) including share option cost

No more posts to show